首页> 美国卫生研究院文献>Journal of Clinical Microbiology >Adamantane- and Oseltamivir-Resistant Seasonal A (H1N1) and Pandemic A (H1N1) 2009 Influenza Viruses in Guangdong China during 2008 and 2009
【2h】

Adamantane- and Oseltamivir-Resistant Seasonal A (H1N1) and Pandemic A (H1N1) 2009 Influenza Viruses in Guangdong China during 2008 and 2009

机译:抗金刚烷和Oseltamivir的季节性A(H1N1)和大流行性A(H1N1)2009流感病毒在中国广东省2008和2009年期间

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Adamantane and oseltamivir resistance among influenza viruses is a major concern to public health officials. To determine the prevalence of antiviral-resistant influenza viruses in Guangdong, China, 244 seasonal A (H1N1) and 222 pandemic A (H1N1) 2009 viruses were screened for oseltamivir resistance by a fluorescence-based neuraminidase (NA) inhibition assay along with NA gene sequencing. Also, 147 seasonal A (H1N1) viruses were sequenced to detect adamantane resistance markers in M2. Adamantane-resistant seasonal A (H1N1) viruses clustering to clade 2C were dominant in 2008, followed by oseltamivir-resistant seasonal A (H1N1) viruses, clustering to clade 2B during January and May 2009. In June 2009, a lineage of double-resistant seasonal A (H1N1) viruses emerged, until it was replaced by the pandemic A (H1N1) 2009 viruses. The lineage most likely resulted from reassortment under the pressure of the overuse of adamantanes. As all viruses were resistant to at least one of the two types of antiviral agents, the need for close monitoring of the prevalence of antiviral resistance is stressed.
机译:流感病毒中的金刚烷和奥司他韦耐药性是公共卫生官员的主要关切。为了确定在中国广东省的抗病毒抗性流感病毒的流行情况,通过基于荧光的神经氨酸酶(NA)抑制分析和NA基因筛选了244株季节性A(H1N1)和222例大流行A(H1N1)2009病毒对奥司他韦的耐药性排序。同样,对147种季节性A(H1N1)病毒进行了测序,以检测M2中的金刚烷抗性标记。耐金刚烷的季节性A(H1N1)病毒在2C进化枝中占主导地位,其次是耐奥司他韦的季节性A(H1N1)病毒,于2009年1月和2009年5月聚类于2B进化枝。2009年6月,双重抗性谱系季节性A(H1N1)病毒出现,直到被2009年大流行A(H1N1)病毒取代。血统很可能是由于在过度使用金刚烷的压力下进行的重组而造成的。由于所有病毒均对两种抗病毒剂中的至少一种具有抗性,因此需要密切监控抗病毒抗性的发生率。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号